Dexmedetomidine Hydrochloride Injection
Product Images NDC 25021-617
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 25021-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Bag Label (Dex21 0000 02)
This is a description of a medication containing Dexmedetomidine HCI in 0.9% Sodium Chloride Injection. Each 100 mL single-dose flexible container contains 400 mcg. It is for intravenous infusion and ready to use without dilution. Each mL contains 4 mcg of dexmedetomidine HCI USP and 9 mg of sodium chloride. The pH ranges from 4.5 to 7.0. It is essential not to add supplementary medication or use in series connections. The usual dosage can be found in the package insert. The solution must be clear before use and should not be used if the container leaks or shows any damage. It should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Avoid freezing the medication. Unused portions should be discarded properly.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.